Single-cell motility and gene expression signature as predictors of the overall survival of act in melanoma patients
Main Authors: | Martinez-Paniagua, Melisa, Haymaker, Cara, Adolacion, Jay R, Radvanyi, Laszlo, Hwu, Patrick, Roysam, Badrinath, Bernatchez, Chantale, Varadarajan, Navin |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645448/ |
Similar Items
-
PD-1 and BTLA and CD8+ T-cell “exhaustion” in cancer: “Exercising” an alternative viewpoint
by: Haymaker, Cara, et al.
Published: (2012) -
Identification of predictive biomarker signatures in melanoma tumors associated with response to tumor-infiltrating lymphocyte (TIL) therapy
by: Chen, Jie Qing, et al.
Published: (2013) -
Single cell metrics of the efficacy of CAR T cells
by: Romain, Gabrielle, et al.
Published: (2015) -
You can run but you can't hide: tracking T cells in metastatic melanoma patients treated with tumor-infiltrating lymphocytes
by: Haymaker, Cara, et al.
Published: (2015) -
BTLA marks a less-differentiated tumor-infiltrating lymphocyte subset in melanoma with enhanced survival properties
by: Haymaker, Cara L, et al.
Published: (2015)